3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelomonocytic, Acute
4
Leukemia, Myeloid, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Erythroblastic, Acute
4
Lymphoma, Non-Hodgkin
3
Wilms Tumor
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Melanoma
2
Medulloblastoma
2
Leukemia, Myelomonocytic, Chronic
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Congenital Abnormalities
2
Breast Neoplasms
2
Brain Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Xanthogranuloma, Juvenile
1
Interventions
fludarabine phosphate
31
Peripheral Blood Stem Cell Transplantation
26
Cyclophosphamide
25
Mycophenolic Acid
24
Whole-Body Irradiation
23
Busulfan
21
Tacrolimus
19
Cyclosporine
19
Antilymphocyte Serum
14
Methotrexate
13
Imatinib Mesylate
12
Cord Blood Stem Cell Transplantation
11
Melphalan
10
Dasatinib
10
Cyclosporins
8
nilotinib
7
Methylprednisolone
7
Etoposide
7
Radiotherapy
6
Filgrastim
6
Alemtuzumab
6
Sirolimus
5
thymoglobulin
4
sargramostim
4
bosutinib
4
Granulocyte Colony-Stimulating Factor
4
Cytarabine
4
fludarabine
3
Thiotepa
3
Rituximab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myeloid, Chronic-Phase
×
tipifarnib
×
Clear all
No trials found.